Understanding Motor Function in Stroke Patients and Their Functional Brain Reorganization Using Ultra High-field MRI
MOTIF-STROKE
1 other identifier
interventional
110
1 country
1
Brief Summary
The MOTIF-STROKE study is embedded within the BrainSync project, aiming to develop innovative strategies for motor rehabilitation of the upper limb. The primary goal is to construct a high-resolution anatomo-functional disconnection atlas in a cohort of 100 stroke patients, using cutting-edge 3T and 7T MRI. Data acquisition, commencing in Fall 2025, will combine morphological (T1-weighted), functional and diffusion-weighted MRI scans to perform morphometry, functional and structural connectivity analyses with biomarkers of motor deficits. This atlas seeks to correlate connectivity with motor tasks, using dedicated task-related fMRI paradigms and digital consultation tools. The project utilizes machine learning algorithms and functional hyper-alignment to analyze fMRI data, focusing on input features and their impact on prediction accuracy. The ultimate objective is to optimize implantation of WIMAGINE neuroprostheses for the subsequent BCI4STROKE clinical trial. Expected results include identifying clinical subgroups responsive to motor intention decoding, characterizing phenotypes of functional reorganization, and making the 3D brain atlas accessible to the neuroscience community.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Dec 2025
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2025
CompletedFirst Submitted
Initial submission to the registry
January 5, 2026
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
January 14, 2026
December 1, 2025
1.9 years
January 5, 2026
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction accuracy of AI models for individual motor action intention
Validation of AI model predictions based on post-processing of functional MRI signals will be performed by comparing them with observed clinical performance during intentional motor tasks. These include assessment of movement intention of the hand and foot, intended movement direction, pathological side, and healthy side.
1 day
Study Arms (1)
Chronic-Phase Ischemic Stroke Patients and Healthy Volunteer Optimization
OTHERParticipants undergo task-based and resting-state fMRI sessions. Imaging and clinical data are collected and analyzed using artificial intelligence models.
Interventions
Participants undergo task-based and resting-state fMRI sessions, including motor imagery and motor execution tasks. Brain activity and clinical data are collected for analysis.
Eligibility Criteria
You may qualify if:
- Patients
- Persistent upper-limb motor deficit resulting from the stroke.
- Absence of significant cognitive impairment: MMSE score ≥ 27 assessed as part of clinical care.
- Age between 18 and 70 years.
- Signed informed consent after clear and fair information about the study.
- Healthy volunteers:
- Age between 18 and 70 years.
- No history of neurological or psychiatric disease.
- Signed informed consent after clear and fair information about the study.
You may not qualify if:
- Patients:
- Recurrent stroke.
- Severe aphasia or severe speech disorders preventing adequate interaction for the protocol.
- Severe auditory or visual impairment.
- Disorders of comprehension, attention, or neglect affecting understanding of study motor tasks.
- Associated conditions with an estimated life expectancy of less than 2 years.
- History of brain surgery, craniectomy, or cranioplasty.
- Other causes of motor disability.
- Alcohol consumption the day before or on the day of the examination, or use of illicit psychotropic substances within 48 hours prior to MRI.
- Absolute contraindications to MRI, including pregnancy; intracorporeal metallic foreign bodies; pacemakers; non-MRI-compatible neurostimulators; cochlear implants; implanted medical devices (electronic or non-electronic) implanted for less than 6 weeks; metallic heart valves; stents, coils, carotid or neurosurgical clips; implantable ports; infusion pumps; non-removable piercings; tattoos or permanent makeup larger than 5 cm on the head, neck, trunk, or upper limbs; transdermal devices with metallic components; intrauterine devices (except Mirena); dental appliances larger than 4 cm; or health conditions incompatible with MRI comfort and safety (e.g., acute respiratory or cardiac failure, inability to remain supine, bedridden state, claustrophobia).
- Individuals not covered by a social security system.
- Individuals under enhanced protection, including pregnant or breastfeeding women, persons deprived of liberty, legally protected adults, or patients in emergency situations.
- Pregnant or breastfeeding women, or women of childbearing potential refusing a pregnancy test.
- Healthy volunteer:
- Absolute contraindications to MRI as listed above.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NeuroSpin, CEA
Gif-sur-Yvette, Île-de-France Region, 91191, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Myriam Edjlali-Goujon, MD, PhD
Commissariat A L'energie Atomique
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
January 5, 2026
First Posted
January 14, 2026
Study Start
December 10, 2025
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
January 1, 2029
Last Updated
January 14, 2026
Record last verified: 2025-12